Concerns Rising Over Risk that Ozempic May Cause Birth Control to Fail
Health experts urge women not to use Ozempic or similar drugs to increase fertility, due to increased risks of birth defects and miscarriage.
Health experts urge women not to use Ozempic or similar drugs to increase fertility, due to increased risks of birth defects and miscarriage.
The U.S. District Judge recently appointed to preside over all federal GLP-1 RA lawsuits is expected to appoint a group of Ozempic lawyers to take certain actions during the MDL proceedings that benefit all plaintiffs.
FDA approved expanded use of Wegovy for cardiovascular disease caused by being overweight, as concerns continue to grow about reports of stomach paralysis injuries some users are experiencing.
Drug maker plans to pursue legal remedies against compounding pharmacies, medical spas and other entities that claim to sell generic versions of Mounjaro and Zepbound.
Despite reported problems dating back to 2010, Novo Nordisk failed to warn doctors and users of Ozempic and Trulicity about the risk of gastroparesis, lawsuit warns.
New York woman indicates she had to undergo an emergency resection of her bowels and now needs to use a colostomy bag as a result of gastroparesis and intestinal obstructions from Mounjaro
Lawyers involved in stomach paralysis lawsuits against Ozempic, Wegovy and other GLP-1 medication manufacturers will meet with the judge to discuss the organizational structure of the recently formed MDL.
Illinois woman required multiple emergency visits due to an Ozempic intestinal blockage, according to a lawsuit filed against the drug maker over inadequate warnings provided about the potential stomach side effects
New research has highlighted the risk of gastric illnesses associated with 15 different types of GLP-1 drugs commonly prescribed for Type II diabetes and weight loss management.
MDL Panel rejected Eli Lilly's request to exclude Mounjaro lawsuits from other GLP-1 stomach paralysis lawsuits against Novo Nordisk, which manufactures Ozempic, Wegovy and Rybelsus.